Immunologic Factors

"Immunologic Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Biologically active substances whose activities affect or play a role in the functioning of the immune system.

Descriptor ID	D007155
MeSH Number(s)	D27.505.696.477
Concept/Terms	Immunologic Factors Immunologic Factors Immune Factors Factors, Immune Immunological Factors Factors, Immunological Factors, Immunologic Immunomodulators Immunomodulators Biological Response Modifiers Biological Response Modifiers Biomodulators Modifiers, Biological Response Response Modifiers, Biological

Below are MeSH descriptors whose meaning is more general than "Immunologic Factors".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Immunologic Factors [D27.505.696.477]

Below are MeSH descriptors whose meaning is more specific than "Immunologic Factors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Immunologic Factors" by people in this website by year, and whether "Immunologic Factors" was a major or minor topic of these publications.

Bar chart showing 96 publications over 21 distinct years, with a maximum of 8 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	2	1	3
2005	2	3	5
2006	6	0	6
2007	5	1	6
2008	1	3	4
2009	4	3	7
2010	4	1	5
2011	4	2	6
2012	2	1	3
2013	1	1	2
2014	5	1	6
2015	1	1	2
2016	5	3	8
2017	6	1	7
2018	2	1	3
2019	2	2	4
2020	1	5	6
2021	3	2	5
2022	1	3	4
2024	0	1	1
2025	3	0	3

Below are the most recent publications written about "Immunologic Factors" by people in Profiles.

Basham KJ, Ward RA, Vyas JM, Nolling Jensen K. Immunomodulatory functions of fungal melanins in respiratory infections. mBio. 2026 Jan 14; 17(1):e0214125.

View in: PubMed
Hahn PA, Shandilya S, da Costa LAB, da Silva LCF, O'Hagan D, Liang B, Engelman K, Gardner MR, Gao G, Fuchs SP, Martinez-Navio JM, Desrosiers RC, Ardeshir A, Magnani DM, Martins MA. The Immunogenicity of AAV-Encoded HIV-1 bNAbs in Rhesus Macaques Is Unaffected by a Short Course of the Immunomodulator CTLA4Ig. AIDS Res Hum Retroviruses. 2025 Dec; 41(12):567-579.

View in: PubMed
Zhang J, Hu Q, Ma G, Su A, Zhao L, Du H, Xiao H. Absorption and immune-modulating effects of active peptides from Hericium erinaceus proteins in an in vitro gastrointestinal model. Food Funct. 2025 Jun 03; 16(11):4535-4547.

View in: PubMed
Yang Y, Du Y, Ivanov D, Niu C, Clare R, Smith JW, Nazy I, Kaltashov IA. Molecular architecture and platelet-activating properties of small immune complexes assembled on heparin and platelet factor 4. Commun Biol. 2024 03 11; 7(1):308.

View in: PubMed
Sklavenitis-Pistofidis R, Aranha MP, Redd RA, Baginska J, Haradhvala NJ, Hallisey M, Dutta AK, Savell A, Varmeh S, Heilpern-Mallory D, Ujwary S, Zavidij O, Aguet F, Su NK, Lightbody ED, Bustoros M, Tahri S, Mouhieddine TH, Wu T, Flechon L, Anand S, Rosenblatt JM, Zonder J, Vredenburgh JJ, Boruchov A, Bhutani M, Usmani SZ, Matous J, Yee AJ, Jakubowiak A, Laubach J, Manier S, Nadeem O, Richardson P, Badros AZ, Mateos MV, Trippa L, Getz G, Ghobrial IM. Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. Cancer Cell. 2022 11 14; 40(11):1358-1373.e8.

View in: PubMed
Molina-Cerrillo J, Santoni M, Ruiz ?, Massari F, Pozas J, Ortego I, G?mez V, Grande E, Alonso-Gordoa T. Epigenetics in advanced renal cell carcinoma: Potential new targets. Crit Rev Oncol Hematol. 2022 Dec; 180:103857.

View in: PubMed
Molina-Cerrillo J, Santoni M, Ruiz ?, Massari F, Pozas J, Ortego I, G?mez V, Grande E, Alonso-Gordoa T. Epigenetics in advanced renal cell carcinoma: Potential new targets. Crit Rev Oncol Hematol. 2022 Dec; 180:103857.

View in: PubMed
Huang K, Liu X, Han G, Zhou Y. Nano-optogenetic immunotherapy. Clin Transl Med. 2022 09; 12(9):e1020.

View in: PubMed
Santoni M, Molina-Cerrillo J, Massari F, Montironi R, Grande E. Re: Effect of Immunotherapy Time-of-day Infusion on Overall Survival Among Patients with Advanced Melanoma in the USA (MEMOIR): A Propensity Score-matched Analysis of a Single-centre, Longitudinal Study. Eur Urol. 2022 06; 81(6):623-624.

View in: PubMed
Covarrubias G, Moon TJ, Loutrianakis G, Sims HM, Umapathy MP, Lorkowski ME, Bielecki PA, Wiese ML, Atukorale PU, Karathanasis E. Comparison of the uptake of untargeted and targeted immunostimulatory nanoparticles by immune cells in the microenvironment of metastatic breast cancer. J Mater Chem B. 2022 01 05; 10(2):224-235.

View in: PubMed

People

Explore

Similar Concepts

Top Journals